Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Envista Holdings Corporation Common Stock (NY:NVST)

28.38 -0.59 (-2.05%)
Streaming Delayed Price Updated: 10:42 AM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Envista Holdings Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Expert Ratings For Envista Holdings ↗
 
Via Benzinga
News headline image
7 Analysts Have This to Say About Envista Holdings ↗
 
Via Benzinga
News headline image
3 Stocks Primed to Get a Post-Halloween Lift ↗
Now that Halloween is over, the bill for trick or treating will soon come due. Here are three stocks to buy to play the dental industry. 
Via InvestorPlace
News headline image
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
News headline image
Dental Firm Envista Q3 Performance Disappoints, Uncertainty, Macro Headwinds To In Short Term ↗
Wednesday, after close, Envista Holdings Corporation (NYSE: NVST) reported Q3< 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket ↗
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently announced the receipt of the Nasdaq delisting... 
Via Benzinga
News headline image
Etsy, Albemarle, SolarEdge Technologies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Earnings Preview: Envista Holdings ↗
 
Via Benzinga
News headline image
Envista Holdings's Return on Invested Capital Insights ↗
 
Via Benzinga
News headline image
Envista Holdings: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Envista Holdings Earnings Preview ↗
 
Via Benzinga
News headline image
A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher ↗
Wall Street has high hopes for these stocks to buy for the next bull market. Consider adding them to your portfolio. 
Via InvestorPlace
News headline image
Hey, Warren! 3 Stocks Buffett Should Buy Now. ↗
While it’s almost certain the billionaire doesn’t need any investing advice, here are three stocks Warren Buffett should buy now. 
Via InvestorPlace
News headline image
DEXIS Announces Intraoral Scanner Software Integration with EasyRx
Via ACCESSWIRE
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
DEXIS IOS Solutions Expands Its Portfolio and Ecosystem, Bringing New End-to-End Digital Workflows to Dental Practitioners
Via ACCESSWIRE
News headline image
Where Envista Holdings Stands With Analysts ↗
Analysts have provided the following ratings for Envista Holdings (NYSE:NVST) within the last quarter: 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Envista Holdings ↗
Envista Holdings (NYSE:NVST) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Beware Spins From Danaher’s Well-Oiled M&A Machine ↗
The $200 billion conglomerate runs acquisitions through its signature kaizen-based system, delivering improvements that churn out model returns for shareholders. When parts are spun back out, however,... 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022 ↗
Upgrades 
Via Benzinga
News headline image
SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers ↗
Citigroup raised the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $13 to $16. MacroGenics shares rose 4.8% to $3.90 in pre-market trading. 
Via Benzinga
News headline image
Looking Into Envista Holdings Return On Invested Capital ↗
  
Via Benzinga
News headline image
4 Analysts Have This to Say About Envista Holdings ↗
Analysts have provided the following ratings for Envista Holdings (NYSE:NVST) within the last quarter: 
Via Benzinga
News headline image
Analyst Ratings for Envista Holdings ↗
Within the last quarter, Envista Holdings (NYSE:NVST) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings For Envista Holdings ↗
Envista Holdings (NYSE:NVST) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Envista Holdings's Return On Capital Employed Overview ↗
Pulled from Benzinga Pro data, Envista Holdings (NYSE:NVST) posted Q1 earnings of $74.90 million, an increase from Q4 of 12.7%. Sales dropped to $631.40 million, a 3.13% decrease between quarters. 
Via Benzinga
News headline image
Envista Holdings: Q1 Earnings Insights ↗
Envista Holdings (NYSE:NVST) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Envista Holdings beat estimated... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.